SPY311.36-0.82 -0.26%
DIA263.33+0.16 0.06%
IXIC9,615.81-67.10 -0.69%
News
EARS
--
0.00%
--
61 Stocks Moving In Tuesday's Mid-Day Session
Gainers Mmtec, Inc. (NASDAQ: MTC) shares jumped 98.2% to $2.18 in pre-market trading after reporting its financial results for the year ended December 31, 2019. Revenues jumped 647% to $200,797, in 2019.
Benzinga · 05/26 16:29
Auris Medical Announces Positive Top-Line Data from AM-201 Phase 1b Study in Antipsychotic-Induced Weight Gain and Provides Update on TRAVERS Phase 2 Study
GlobeNewswire · 05/26 13:30
The Week Ahead In Biotech: Virtual Conference Presentations, Clovis PDUFA Date In The Spotlight
The smid-cap biotech earnings deluge hit Wall Street in the week ended May 9, positively impacting the stocks in the sector. The iShares NASDAQ Biotechnology Index (NASDAQ: IBB) gained about 6% for the week.
Benzinga · 05/10 19:40
Here's Why We Worry About Auris Medical Holding's (NASDAQ:EARS) Cash Burn Situation
Simply Wall St. · 05/10 15:39
The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace
Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma names, including Merck & Co., Inc. (NYSE: MRK) and Pfizer Inc.
Benzinga · 05/03 12:46
Auris Medical reports FY results
seekingalpha · 04/16 16:04
Auris Medical Provides Business Update and Reports Second Half and Full Year 2019 Financial Results
GlobeNewswire · 04/16 12:00
Auris Medical FY19 Total Opex CHF 7.3M vs CHF11M In FY18, EPS CHF(2.28) vs CHF(14.46) In FY18
Benzinga · 04/16 11:04
Auris Medical Provides Update on Intranasal Betahistine Development Program
GlobeNewswire · 04/03 22:00
Auris Medical Holding Ltd. to Host Earnings Call
ACCESSWIRE · 03/26 11:00
Auris Medical Holding Ltd. to Host Earnings Call
ACCESSWIRE · 03/19 11:00
Auris Medical advancing intranasal betahistine studies
Seeking Alpha - Article · 03/05 16:33
Auris Medical Reports Last Subject Had Last Treatment In Phase 1b Trial Of AM-201, Sees Data Early May
Benzinga · 03/05 13:33
Auris Medical Provides Update on Ongoing Clinical Trials with Intranasal Betahistine
GlobeNewswire · 03/05 13:30
The Daily Biotech Pulse: Sangamo In Genome-Editing Therapy Deal With Biogen, FDA Nod For Biohaven, Passage Bio IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 27)
Benzinga · 02/28 12:28
Auris Medical Highlights Publication of Study Results Demonstrating Betahistines Antiepileptogenic and Anticonvulsant Activity in Murine Model
GlobeNewswire · 02/25 13:30
Should You Take Comfort From Insider Transactions At Auris Medical Holding Ltd. (NASDAQ:EARS)?
Simply Wall St. · 02/10 15:01
Comcast -1.2% as UBS sees investments weighing growth
Seeking Alpha - Article · 01/24 14:30
Here are the biggest analyst calls of the day: Alphabet, Apple, PayPal, Intel & more
Here are the biggest calls on Wall Street on Friday
CNBC.com · 01/24 14:01
ClearBridge Multi Cap Growth Strategy Portfolio Manager Commentary Q4 2019
Seeking Alpha - Article · 01/24 12:35